Treating Periodontal Disease In The Post-Antibiotic Age
Treating periodontal disease not only improves oral health, it also reduces a chronic infectious burden on patients’ immune systems. Unfortunately, it is one of the most underdiagnosed diseases. Forty-seven percent of American adults have chronic periodontitis. However, according to Dental Intel, only 8% of patients get treatment planned for D4341 and D4342. Of that 8%, only half accept the treatment. Without a diagnosis, patients cannot make informed decisions or get the care they need.
Antibiotic adjunctive therapies have a temporary, limited effect. This is because biofilms repopulate after usage and because we are in the post-antibiotic age. A broad-spectrum antimicrobial like hydrogen peroxide is an excellent alternative for patients with gingivitis, periodontitis, peri-implant mucositis, and peri-implantitis. Attend this presentation to learn the science behind the use of peroxide for the treatment of biofilm-based diseases.
- Identify the benefits and limitations of antimicrobials with oxidative and oxygenating reactions for biofilm management.
- Recognize patient candidates who can benefit from Rx Tray therapy of peroxide.
- Evaluate clinical cases and the efficacy of peroxide in treatment.
- breakfast & registration: 8am
- lecture: 9am to 1pm